1 year agoBioVie: Potential Blockbuster Late-Stage Programs Targeting Alzheimer’s & Parkinson’sRedChip
1 year agoFrom Malaria to COVID-19: Sixty Degrees Pharma CEO Geoff Dow's Perspective on Infectious Disease SolutionsRedChip
1 year agoUnicycive Therapeutics: Addressing a $2.5 Billion Global Market Opportunity in Kidney DiseaseRedChip
1 year agoRevolutionizing Medicine: A Conversation with BullFrog AI's CEO on AI-Driven Drug DevelopmentRedChip
1 year agoIn the Spotlight: BioVie's (NASDAQ: BIVI) Quest to Tackle Alzheimer's, Parkinson's, and MoreRedChip
11 months agoBioVie(NASDAQ:BIVI): Advancing Transformative Therapies for Neurodegeneration and Liver DiseaseRedChip
1 year agoHow a Catastrophic Three-Train Collision Could Have Been Potentially Avoided with Rail VisionRedChip
1 year agoIn-Depth Discussion with ASP Isotopes' CEO, Paul Mann: Pioneering Isotope TechnologyRedChip